XBP1 Human Gene Knockout Kit (CRISPR)

SKU
KN201959
XBP1 - human gene knockout kit via CRISPR, HDR mediated
  $1,657.00
4 Weeks*
Specifications
Specifications
Product Data
Format 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control
Vector GFP-puro
Target Symbol XBP1
Locus ID 7494
Components

KN201959G1, XBP1 gRNA vector 1 in pCas-Guide CRISPR vector, Target Sequence: ACTTTAGGGGTCCCGTCGGC

KN201959G2, XBP1 gRNA vector 2 in pCas-Guide CRISPR vector, Target Sequence: CCCGTCGGCCGGGTTCGGCG

KN201959D, donor DNA containing left and right homologous arms and GFP-puro functional cassette.

Homologous arm and GFP-puro sequences:

pUC vector backbone in gray; Left arm sequence in blue; GFP-puro in green; Right arm in violet

GATCGTTGGG AACCGGAGCT GAATGAAGCC ATACCAAACG ACGAGCGTGA CACCACGATG CCTGTAGCAA TGGCAACAAC GTTGCGCAAA CTATTAACTG GCGAACTACT TACTCTAGCT TCCCGGCAAC AATTAATAGA CTGGATGGAG GCGGATAAAG TTGCAGGACC ACTTCTGCGC TCGGCCCTTC CGGCTGGCTG GTTTATTGCT GATAAATCTG GAGCCGGTGA GCGTGGTTCT CGCGGTATCA TTGCAGCACT GGGGCCAGAT GGTAAGCCCT CCCGTATCGT AGTTATCTAC ACGACGGGGA GTCAGGCAAC TATGGATGAA CGAAATAGAC AGATCGCTGA GATAGGTGCC TCACTGATTA AGCATTGGTA ACTGTCAGAC CAAGTTTACT CATATATACT TTAGATTGAT TTAAAACTTC ATTTTTAATT TAAAAGGATC TAGGTGAAGA TCCTTTTTGA TAATCTCATG ACCAAAATCC CTTAACGTGA GTTTTCGTTC CACTGAGCGT CAGACCCCGT AGAAAAGATC AAAGGATCTT CTTGAGATCC TTTTTTTCTG CGCGTAATCT GCTGCTTGCA AACAAAAAAA CCACCGCTAC CAGCGGTGGT TTGTTTGCCG GATCAAGAGC TACCAACTCT TTTTCCGAAG GTAACTGGCT TCAGCAGAGC GCAGATACCA AATACTGTTC TTCTAGTGTA GCCGTAGTTA GGCCACCACT TCAAGAACTC TGTAGCACCG CCTACATACC TCGCTCTGCT AATCCTGTTA CCAGTGGCTG CTGCCAGTGG CGATAAGTCG TGTCTTACCG GGTTGGACTC AAGACGATAG TTACCGGATA AGGCGCAGCG GTCGGGCTGA ACGGGGGGTT CGTGCACACA GCCCAGCTTG GAGCGAACGA CCTACACCGA ACTGAGATAC CTACAGCGTG AGCTATGAGA AAGCGCCACG CTTCCCGAAG GGAGAAAGGC GGACAGGTAT CCGGTAAGCG GCAGGGTCGG AACAGGAGAG CGCACGAGGG AGCTTCCAGG GGGAAACGCC TGGTATCTTT ATAGTCCTGT CGGGTTTCGC CACCTCTGAC TTGAGCGTCG ATTTTTGTGA TGCTCGTCAG GGGGGCGGAG CCTATGGAAA AACGCCAGCA ACGCGGCCTT TTTACGGTTC CTGGCCTTTT GCTGGCCTTT TGCTCACATG TTCTTTCCTG CGTTATCCCC TGATTCTGTG GATAACCGTA TTACCGCCTT TGAGTGAGCT GATACCGCTC GCCGCAGCCG AACGACCGAG CGCAGCGAGT CAGTGAGCGA GGAAGCGGAA GAGCGCCCAA TACGCAAACC GCCTCTCCCC GCGCGTTGGC CGATTCATTA ATGCAGCTGG CACGACAGGT TTCCCGACTG GAAAGCGGGC AGTGAGCGCA ACGCAATTAA TGTGAGTTAG CTCACTCATT AGGCACCCCA GGCTTTACAC TTTATGCTTC CGGCTCGTAT GTTGTGTGGA ATTGTGAGCG GATAACAATT TCACACAGGA AACAGCTATG ACCATGATTA CGCCAAGCTC CTTCCTCTTC CAGCCCTTCC TCTTTCACTG ACTGACTGAC TGGGTCTCAA CCTGACTTCT ATTCCGCAGA ATTTCTTTCC AGGCTTTTTT CTTTTTCTTT TTTTGAGACG GAGTCTCGCT CTGTCGCCCA GGCCGGGGTG CAGTGGCGCG ATCTCGGCTC ACTGAAACCT CTGTCCAGTC TTTTCGAACC CAAGGCCCAA CTGCGCTCTA TCTCGACTTT CGGCTCCACT CGGATCCCGA AGTGGCGCAC GAGATAAAAT GTTGTCAGGC TGAGGTAATT CTCTGTTAGT CCCGGTAAAA ATTCGTCAGT CTGGAAAGCT CTCGGTTTGG AATTAAATTC TGTCACTCCG GATGGAAATA AGTCCGCTTA AGGGGGGAAA ATCCGTTTGT GGAGGACACG CTCCCGCACG TAACCCCCCG CGGAAAATGA CCCCAAGTAC CTTTGGCCAG GGATTGCCGC TGCCACGCCG GACTCCATAG CCACGGTCCT GAAACGCCCC GCCGGGCAGG CCGGACCAAT GGACGCCGAG CTCGGCCGTG CGTCACGCGA CGCTGGCCAA TCGCGGAGGG CCACGACCGT AGAAAGGCCG GGCGCGGCGA GGCTGGGCGC TGGGCGGCTG CGGCGCGCGG TGCGCGGTGC GTAGTCTGGA GCTACTAGCA TGGAGAGCGA CGAGAGCGGC CTGCCCGCCA TGGAGATCGA GTGCCGCATC ACCGGCACCC TGAACGGCGT GGAGTTCGAG CTGGTGGGCG GCGGAGAGGG CACCCCCGAG CAGGGCCGCA TGACCAACAA GATGAAGAGC ACCAAAGGCG CCCTGACCTT CAGCCCCTAC CTGCTGAGCC ACGTGATGGG CTACGGCTTC TACCACTTCG GCACCTACCC CAGCGGCTAC GAGAACCCCT TCCTGCACGC CATCAACAAC GGCGGCTACA CCAACACCCG CATCGAGAAG TACGAGGACG GCGGCGTGCT GCACGTGAGC TTCAGCTACC GCTACGAGGC CGGCCGCGTG ATCGGCGACT TCAAGGTGAT GGGCACCGGC TTCCCCGAGG ACAGCGTGAT CTTCACCGAC AAGATCATCC GCAGCAACGC CACCGTGGAG CACCTGCACC CCATGGGCGA TAACGATCTG GATGGCAGCT TCACCCGCAC CTTCAGCCTG CGCGACGGCG GCTACTACAG CTCCGTGGTG GACAGCCACA TGCACTTCAA GAGCGCCATC CACCCCAGCA TCCTGCAGAA CGGGGGCCCC ATGTTCGCCT TCCGCCGCGT GGAGGAGGAT CACAGCAACA CCGAGCTGGG CATCGTGGAG TACCAGCACG CCTTCAAGAC CCCGGATGCA GATGCCGGTG AAGAAAGAGT TTAAGAATTC CGATCATATT CAATAACCCT TAATATAACT TCGTATAATG TATGCTATAC GAAGTTATTA GGTCTGAAGA GGAGTTTACG TCCAGCCAAG CTTAGGATCT CGACCTCGAA ATTCTACCGG GTAGGGGAGG CGCTTTTCCC AAGGCAGTCT GGAGCATGCG CTTTAGCAGC CCCGCTGGGC ACTTGGCGCT ACACAAGTGG CCTCTGGCCT CGCACACATT CCACATCCAC CGGTAGGCGC CAACCGACTC CGTTCTTTGG TGGCCCCTTC GCGCCACCTT CTACTCCTCC CCTAGTCAGG AAGTTCCCCC CCGCCCCGCA GCTCGCGTCG TGCAGGACGT GACAAATGGA AGTAGCACGT CTCACTAGTC TCGTGCAGAT GGACAGCACC GCTGAGCAAT GGAAGCGGGT AGGCCTTTGG GGCAGCGGCC AATAGCAGCT TTGCTCCTTC GCTTTCTGGG CTCAGAGGCT GGGAAGGGGT GGGTCCGGGG GCGGGCTCAG GGGCGGGCTC AGGGGCGGGG CGGGCGCCCG AAGGTCCTCC GGAGGCCCGG CATTCTGCAC GCTTCAAAAG CGCACGTCTG CCGCGCTGTT CTCCTCTTCC TCATCTCCGG GCCTTTCGAC CTGCATCCAT CTAGATCTCG AGCAGCTGAA GCTTACCATG ACCGAGTACA AGCCCACGGT GCGCCTCGCC ACCCGCGACG ACGTCCCCAG GGCCGTACGC ACCCTCGCCG CCGCGTTCGC CGACTACCCC GCCACGCGCC ACACCGTCGA TCCGGACCGC CACATCGAGC GGGTCACCGA GCTGCAAGAA CTCTTCCTCA CGCGCGTCGG GCTCGACATC GGCAAGGTGT GGGTCGCGGA CGACGGCGCC GCGGTGGCGG TCTGGACCAC GCCGGAGAGC GTCGAAGCGG GGGCGGTGTT CGCCGAGATC GGCCCGCGCA TGGCCGAGTT GAGCGGTTCC CGGCTGGCCG CGCAGCAACA GATGGAAGGC CTCCTGGCGC CGCACCGGCC CAAGGAGCCC GCGTGGTTCC TGGCCACCGT CGGCGTCTCG CCCGACCACC AGGGCAAGGG TCTGGGCAGC GCCGTCGTGC TCCCCGGAGT GGAGGCGGCC GAGCGCGCCG GGGTGCCCGC CTTCCTGGAG ACCTCCGCGC CCCACAACCT CCCCTTCTAC GAGCGGCTCG GCTTCACCGT CACCGCCGAC GTCGAGGTGC CCGAAGGACC GCGCACCTGG TGCATGACCC GCAAGCCCGG TGCCTGACGC CCGCCCCACG ACCCGCAGCG CCCGACCGAA AGGAGCGCAC GACCCCATGC ATCGATGATA TCAGATCCCC GGGATGCAGA AATTGATGAT CTATTAAACA ATAAAGATGT CCACTAAAAT GGAAGTTTTT CCTGTCATAC TTTGTTAAGA AGGGTGAGAA CAGAGTACCT ACATTTTGAA TGGAAGGATT GGAGCTACGG GGGTGGGGGT GGGGTGGGAT TAGATAAATG CCTGCTCTTT ACTGAAGGCT CTTTACTATT GCTTTATGAT AATGTTTCAT AGTTGGATAT CATAATTTAA ACAAGCAAAA CCAAATTAAG GGCCAGCTCA TTCCTCCCAC TCATGATCTA TAGATCTATA GATCTCTCGT GGGATCATTG TTTTTCTCTT GATTCCCACT TTGTGGTTCT AAGTACTGTG GTTTCCAAAT GTGTCAGTTT CATAGCCTGA AGAACGAGAT CAGCAGCCTC TGTTCCACAT ACACTTCATT CTCAGTATTG TTTTGCCAAG TTCTAATTCC ATCAGAAGCT GGTCGAGATC CGGAACCCTT AATATAACTT CGTATAATGT ATGCTATACG AAGTTATTAG GTCCCTCGAA GAGGTTCACT AGGCGCGCCC TCATGGTGCC AGCCCAGAGA GGGGCCAGCC CGGAGGCAGC GAGCGGGGGG CTGCCCCAGG CGCGCAAGCG ACAGCGCCTC ACGCACCTGA GCCCCGAGGA GAAGGCGCTG AGGAGGTGGG CGAGGGGCCG GGGTCTGGGG CCAGATCTGA AGCCGGGACT AGGGACAGGG GCAGGGGCAG GGGCTGGGAG CGGGGACCCA GCACTGGCCG CCCCGCAGGG CTCCGTCGCC TTTGGCCTGG CGGGTCGGTG CCAGCGTGGC GCGGGGCGGG GCAGGAAGCC CGGACTGACC GGATCCGCCA CGCTGGGAAC CTAGGGCGGC CCAGGGCTCT TTTCTGTACT TTTTAACTCT CTCGTTAGAG ATGACCAGAG CTGGGGATGC GGGCACCTGT CTTCCAGGCC CTCTTGCTGT GTGGCCGCAG ACTGGTGGTT CAGCCTCTTA ACTCGGACAT GAGGTCGAAT AATCTGTTTT GGTTTACTGC TATTTCTGGA GAGGCGCGGA GCTGAAATAA CAGAGCTGTT GAAAGGGCTG GGAATTCTGC GAGGCTCACT GGTCTAGCTC AGTATCTGCG TTCTTAAAAT GGAACCTACT TCATGAGGTA CGAAGAGACC ACTGACTGAC TGACTGGAAA GTCCTCTCCA CTGACTGTAG CCTCCAATTC ACTGGCCGTC GTTTTACAAC GTCGTGACTG GGAAAACCCT GGCGTTACCC AACTTAATCG CCTTGCAGCA CATCCCCCTT TCGCCAGCTG GCGTAATAGC GAAGAGGCCC GCACCGATCG CCCTTCCCAA CAGTTGCGCA GCCTGAATGG CGAATGGCGC CTGATGCGGT ATTTTCTCCT TACGCATCTG TGCGGTATTT CACACCGCAT ACGTCAAAGC AACCATAGTA CGCGCCCTGT AGCGGCGCAT TAAGCGCGGC GGGTGTGGTG GTTACGCGCA GCGTGACCGC TACACTTGCC AGCGCCCTAG CGCCCGCTCC TTTCGCTTTC TTCCCTTCCT TTCTCGCCAC GTTCGCCGGC TTTCCCCGTC AAGCTCTAAA TCGGGGGCTC CCTTTAGGGT TCCGATTTAG TGCTTTACGG CACCTCGACC CCAAAAAACT TGATTTGGGT GATGGTTCAC GTAGTGGGCC ATCGCCCTGA TAGACGGTTT TTCGCCCTTT GACGTTGGAG TCCACGTTCT TTAATAGTGG ACTCTTGTTC CAAACTGGAA CAACACTCAA CCCTATCTCG GGCTATTCTT TTGATTTATA AGGGATTTTG CCGATTTCGG CCTATTGGTT AAAAAATGAG CTGATTTAAC AAAAATTTAA CGCGAATTTT AACAAAATAT TAACGTTTAC AATTTTATGG TGCACTCTCA GTACAATCTG CTCTGATGCC GCATAGTTAA GCCAGCCCCG ACACCCGCCA ACACCCGCTG ACGCGCCCTG ACGGGCTTGT CTGCTCCCGG CATCCGCTTA CAGACAAGCT GTGACCGTCA ACGGGAGCTG CATGTGTCAG AGGTTTTCAC CGTCATCACC GAAACGCGCG ACCCGAAAGG GCCTCGTGAT ACGCCTATTT TTATAGGTTA ATGTCATGAT AATAATGGTT TCTTAGACGT CAGGTGGCAC TTTTCGGGGA AATGTGCGCG GAACCCCTAT TTGTTTATTT TTCTAAATAC ATTCAAATAT GTATCCGCTC ATGAGACAAT AACCCTGATA AATGCTTCAA TAATATTGAA AAAGGAAGAG TATGAGTATT CAACATTTCC GTGTCGCCCT TATTCCCTTT TTTGCGGCAT TTTGCCTTCC TGTTTTTGCT CACCCAGAAA CGCTGGTGAA AGTAAAAGAT GCTGAAGATC AGTTGGGTGC ACGAGTGGGT TACATCGAAC TGGATCTCAA CAGCGGTAAG ATCCTTGAGA GTTTTCGCCC CGAAGAACGT TTTCCAATGA TGAGCACTTT TAAAGTTCTG CTATGTGGCG CGGTATTATC CCGTATTGAC GCCGGGCAAG AGCAACTCGG TCGCCGCATA CACTATTCTC AGAATGACTT GGTTGAGTAC TCACCAGTCA CAGAAAAGCA TCTTACGGAT GGCATGACAG TAAGAGAATT ATGCAGTGCT GCCATAACCA TGAGTGATAA CACTGCGGCC AACTTACTTC TGACAACGAT CGGAGGACCG AAGGAGCTAA CCGCTTTTTT GCACAACATG GGGGATCATG TAACTCGCCT T

GE100003, scramble sequence in pCas-Guide vector

OTI Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process.
Reference Data
RefSeq NM_001079539, NM_005080
UniProt ID P17861
Synonyms TREB-5; TREB5; XBP-1; XBP2
Summary This gene encodes a transcription factor that regulates MHC class II genes by binding to a promoter element referred to as an X box. This gene product is a bZIP protein, which was also identified as a cellular transcription factor that binds to an enhancer in the promoter of the T cell leukemia virus type 1 promoter. It may increase expression of viral proteins by acting as the DNA binding partner of a viral transactivator. It has been found that upon accumulation of unfolded proteins in the endoplasmic reticulum (ER), the mRNA of this gene is processed to an active form by an unconventional splicing mechanism that is mediated by the endonuclease inositol-requiring enzyme 1 (IRE1). The resulting loss of 26 nt from the spliced mRNA causes a frame-shift and an isoform XBP1(S), which is the functionally active transcription factor. The isoform encoded by the unspliced mRNA, XBP1(U), is constitutively expressed, and thought to function as a negative feedback regulator of XBP1(S), which shuts off transcription of target genes during the recovery phase of ER stress. A pseudogene of XBP1 has been identified and localized to chromosome 5. provided by RefSeq, Jul 2008
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources
Other Versions
SKU Description Size Price
GA105164 XBP1 CRISPRa kit - CRISPR gene activation of human X-box binding protein 1 1 kit
$1,657.00
KN201959BN XBP1 - human gene knockout kit via CRISPR, HDR mediated 1 kit
$1,657.00
KN201959LP XBP1 - human gene knockout kit via CRISPR, HDR mediated 1 kit
$1,657.00
KN201959RB XBP1 - human gene knockout kit via CRISPR, HDR mediated 1 kit
$1,657.00
KN401959 XBP1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. 1 kit
$1,657.00

file-alt Citations

RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity
Barua, Sultana, Islam et al
BMC Cancer (2023) 23 (1), 288 DOI: 10.1186/s12885-023-10745-1
Cited by 8
AI Summary: OriGene contributed CRISPR guide RNA plasmids targeting XBP1 (Cat# KN201959) and CDC6 overexpression plasmids (Cat# 109,332 and 109,333), which were used to generate XBP1 knockout and CDC6 overexpressing breast cancer cell lines, enabling the study of their roles in endocrine resistance.
Snippet: land. All other chemicals were obtained from Sigma-Aldrich, Wicklow, Ireland, unless otherwise stated. Plasmid constructs CRISPR guide RNA plasmids (Cat# KN201959) targeting XBP1 were purchased from Origene (Cambridge Biosciences, Cambridge, UK). The following plasmids: psPAX2 (Cat# 12,260) and PMD2.G (Cat# 12,259), PCLXSN (Cat# 12,343), CDC6 (Cat # 109,332 and 109,333), and pUMVC (Cat# 8449) wer
FigureFigureFigure
RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity
Barua, Sultana, Islam et al
Research Square (2022)
Snippet: CRISPR guide RNA encoding plasmids (Cat# KN201959) targeting XBP1 were purchased from Origene (Cambridge Biosciences, Cambridge, UK). The following plasmids: PCLXSN (Cat# 12343), 5myc-CDC6- WT (Cat# 109332), 5myc-CDC6-mut (Cat# 109333), psPAX2 (Cat# 12260), PMD2.G (Cat# 12259) a
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer
Almanza, Mnich, Blomme et al
Nat Commun (2022) 13 (1), 2493 DOI: 10.1038/s41467-022-30159-0
Cited by 85
AI Summary: OriGene's TurboFectin transfection reagent (#TF81001) was used to efficiently introduce DNA into cells, enabling the functional studies of IRE1α and its impact on lipid metabolism in cancer described in this paper.
Snippet: …In TNBC, the most aggressive breast cancer subtype, IRE1α activity has been linked to tumorigenesis14, tumor progression12,14, angiogenesis15, metastasis14, remodeling of tumor microenvironment13,15, resistance to anthracycline- or taxane-based chemotherapy12–14 and post-therapy tumor r;- TurboFectin transfection reagent (OriGene #TF81001) was used according to the manufacturer's instructions with a 1:2 ratio of DNA to transfection reagent. …
FigureFigureFigure
XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation
Barua, Abbasi, Gupta et al
Heliyon (2020) 6 (10), e05217 DOI: 10.1016/j.heliyon.2020.e05217
Cited by 12
AI Summary: OriGene’s CRISPR guide RNA plasmids targeting XBP1 (Cat# KN201959) were used in this study to knock down XBP1 expression and investigate its role in modulating endocrine resistance in breast cancer cells.
Snippet: … Lentiviral PLKO control and XBP1-targeting shRNA plasmid (TRCN0000019805) were from Sigma (Wicklow, Ireland). CRISPR guide RNA plasmids targeting XBP1 were purchased from Origene (Cat# KN201959). 2.3 Cell transfection and luciferase reporter assay Luciferase reporter assays were performed as described previously [8]. MCF7 and 293T cells were routinely maintained in DM;- Lentiviral PLKO control and XBP1-targeting shRNA plasmid (TRCN0000019805) were from Sigma (Wicklow, Ireland). CRISPR guide RNA plasmids targeting XBP1 were purchased from Origene (Cat# KN201959). 2.3. …
FigureFigureFigure
Showing 1-4 of 4 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products